The methylation status of MGMT was determined retrospectively from the tumor tissue of 206 patients [22] who were enrolled in the randomized phase III trial where patients with a diagnosis of GBM were treated with concomitant and adjuvant temozolomide and radiotherapy [3]. This evidence concerns the gene MGMT and glioblastoma.